Literature DB >> 11919209

Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency).

A Fay1, M Abinun.   

Abstract

Hereditary angio-oedema is characterised by recurrent swellings in any part of the body and also by recurrent attacks of severe abdominal pain. The disease is inherited in an autosomal dominant manner but up to 25% of cases can occur as a spontaneous mutation. Attacks of swelling can be precipitated by trauma, certain drugs, and emotional stress. Treatment usually involves a combination of prophylaxis, using androgens or antifibrolytic drugs, and replacement with C'1 esterase inhibitor concentrate for acute attacks and before surgery or other traumatic procedures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11919209      PMCID: PMC1769636          DOI: 10.1136/jcp.55.4.266

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  93 in total

1.  Hereditary angioneurotic oedema in Finland. Clinical, immunological and genealogical studies.

Authors:  K Ohela
Journal:  Acta Med Scand       Date:  1977

2.  Hereditary angioedema: the clinical syndrome and its management.

Authors:  M M Frank; J A Gelfand; J P Atkinson
Journal:  Ann Intern Med       Date:  1976-05       Impact factor: 25.391

3.  Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery.

Authors:  C J Jaffe; J P Atkinson; J A Gelfand; M M Frank
Journal:  J Allergy Clin Immunol       Date:  1975-06       Impact factor: 10.793

4.  Tranexamic acid: preoperative prophylactic therapy for patients with hereditary angioneurotic edema.

Authors:  A L Sheffer; D T Fearon; K F Austen; F S Rosen
Journal:  J Allergy Clin Immunol       Date:  1977-07       Impact factor: 10.793

5.  Letter: Liver tumours and steroid hormones.

Authors:  D Cattan; P Vesin; J Wautier; R Kalifat; S Meignan
Journal:  Lancet       Date:  1974-05-04       Impact factor: 79.321

6.  The anesthetic and perioperative management of a patient with documented hereditary angioneurotic edema.

Authors:  P S Gibbs; A M LoSasso; S S Moorthy; C E Hutton
Journal:  Anesth Analg       Date:  1977 Jul-Aug       Impact factor: 5.108

7.  Contributions to the optimal use of human blood. 3. Large-scale preparation of human c1 esterase inhibitor concentrate for clinical use.

Authors:  E F Vogelaar; H G Brummelhuis; H W Krijnen
Journal:  Vox Sang       Date:  1974-02       Impact factor: 2.144

8.  Long-term therapy of hereditary angioedema (HAE). Preventive management with fluoxymesterone and oxymetholone in severely affected males and females.

Authors:  P J Davis; F B Davis; P Charache
Journal:  Johns Hopkins Med J       Date:  1974-12

9.  Hereditary angioneurotic oedema.

Authors:  L Levi
Journal:  Klin Wochenschr       Date:  1975-07-15

10.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities.

Authors:  J A Gelfand; R J Sherins; D W Alling; M M Frank
Journal:  N Engl J Med       Date:  1976-12-23       Impact factor: 91.245

View more
  10 in total

Review 1.  8 management of allergy, rashes, and itching.

Authors:  M Langran; C Laird
Journal:  Emerg Med J       Date:  2004-11       Impact factor: 2.740

2.  Type II hereditary angioedema: presenting as food allergy.

Authors:  Yvonne Williams; Greg Byrne; Sara Lynch; Conleth Feighery; Mohamed Abuzakouk
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

Review 3.  C1 inhibitor deficiency: consensus document.

Authors:  M M Gompels; R J Lock; M Abinun; C A Bethune; G Davies; C Grattan; A C Fay; H J Longhurst; L Morrison; A Price; M Price; D Watters
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

Review 4.  Pediatric angioedema.

Authors:  Anita Krishnamurthy; Stanley M Naguwa; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 5.  C1-inhibitor deficiencies (hereditary angioedema): where are we with therapies?

Authors:  R J Lock; M M Gompels
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

6.  HAE therapies: past present and future.

Authors:  Bruce L Zuraw
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

Review 7.  Brazilian guidelines for the diagnosis and treatment of hereditary angioedema.

Authors:  Pedro Giavina-Bianchi; Alfeu T França; Anete S Grumach; Abílio A Motta; Fátima R Fernandes; Regis A Campos; Solange O Valle; Nelson A Rosário; Dirceu Sole
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

8.  Refractory Angioedema in a Patient with Systemic Lupus Erythematosus.

Authors:  Zahra Habibagahi; Jamshid Ruzbeh; Vahide Yarmohammadi; Malihe Kamali; Mohammad Hassan Rastegar
Journal:  Iran J Med Sci       Date:  2015-07

9.  Membranous nephropathy in a patient with hereditary angioedema: a case report.

Authors:  Sandawana W Majoni; Steven R Smith
Journal:  J Med Case Rep       Date:  2008-10-13

10.  New treatments addressing the pathophysiology of hereditary angioedema.

Authors:  Alvin E Davis
Journal:  Clin Mol Allergy       Date:  2008-04-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.